Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

MCY Outperforms Industry in a Year: Time to Add It for Better Returns?
MCY Outperforms Industry in a Year: Time to Add It for Better Returns?

Mercury General Corporation MCY shares have risen 69.1% in the past year against the industry’s decline of 3.6%. Shares of MCY have outperformed the Finance sector and the Zacks S&P 500 composite’s

Here's Why Investors Should Give Greenbrier Stock a Miss Now
Here's Why Investors Should Give Greenbrier Stock a Miss Now

The Greenbrier Companies GBX is facing significant challenges that are impacting its financial stability. Weak liquidity and challenging macro-economic scenarios are major headwinds hurting the

IREN vs. CIFR: Which AI Data Center Stock Has an Edge Right Now?Photo, wide shot, wide-angle lens,  Telecom equipment supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/ad10ed87-71d0-4096-a50b-ba9470f8264b.png
IREN vs. CIFR: Which AI Data Center Stock Has an Edge Right Now?

IREN Limited IREN and Cipher Digital Inc. CIFR are key players in the artificial intelligence (AI) infrastructure market that offer next-generation data center infrastructure targeting

Reasons Why You Should Retain IFF Stock in Your Portfolio Now
Reasons Why You Should Retain IFF Stock in Your Portfolio Now

International Flavors & Fragrances Inc. IFF is well-positioned to benefit from demand for a variety of consumer products containing flavors and fragrances going forward. Its disciplined approach to

Morgan Stanley Gains 13.2% YTD: Should You Buy the Stock Now?
Morgan Stanley Gains 13.2% YTD: Should You Buy the Stock Now?

Supported primarily by solid first-quarter 2026 results, shares of Morgan Stanley MS have gained 13.2% so far this year, outperforming the S&P 500 Index’s 9.7% growth and the industry’s 2.2%

NIO Q1 Earnings Surpass Expectations on Surging Deliveries
NIO Q1 Earnings Surpass Expectations on Surging Deliveries

NIO Inc. NIO delivered a narrower-than-expected loss in the first quarter of 2026, as strong volume growth and a firmer mix supported profitability. The company reported a loss of 3 cents per

INVH Stock Up 11.4% in Three Months: Will the Momentum Last?
INVH Stock Up 11.4% in Three Months: Will the Momentum Last?

Invitation Homes Inc. INVH shares have risen 11.4% over the past three months against the industry's fall of 2.2%.

The company should benefit from its scaled single-family rental portfolio in infill

Can Willdan (WLDN) Climb 38.96% to Reach the Level Wall Street Analysts Expect?
Can Willdan (WLDN) Climb 38.96% to Reach the Level Wall Street Analysts Expect?

Willdan Group (WLDN) closed the last trading session at $93.55, gaining 20% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a BetPhoto, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet

Nuvectis Pharma, Inc. (NVCT) closed the last trading session at $10.35, gaining 16.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

Wall Street Analysts Believe Atlassian (TEAM) Could Rally 49.75%: Here's is How to Trade
Wall Street Analysts Believe Atlassian (TEAM) Could Rally 49.75%: Here's is How to Trade

Atlassian (TEAM) closed the last trading session at $85.42, gaining 19.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts See a 30.54% Upside in Viavi Solutions (VIAV): Can the Stock Really Move This High?
Wall Street Analysts See a 30.54% Upside in Viavi Solutions (VIAV): Can the Stock Really Move This High?

Viavi Solutions (VIAV) closed the last trading session at $49.51, gaining 3.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade

Biodesix, Inc. (BDSX) closed the last trading session at $14.93, gaining 40.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Think Lifezone Metals Limited (LZM) Could Surge 69.55%: Read This Before Placing a BetPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
Wall Street Analysts Think Lifezone Metals Limited (LZM) Could Surge 69.55%: Read This Before Placing a Bet

Lifezone Metals Limited (LZM) closed the last trading session at $5.09, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set

How Much Upside is Left in Alliance Laundry (ALH)? Wall Street Analysts Think 26.32%
How Much Upside is Left in Alliance Laundry (ALH)? Wall Street Analysts Think 26.32%

Alliance Laundry Holdings (ALH) closed the last trading session at $24.77, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?
Wall Street Analysts See a 51.94% Upside in Carlsmed, Inc. (CARL): Can the Stock Really Move This High?

Carlsmed, Inc. (CARL) closed the last trading session at $12.11, gaining 18.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade
Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade

Adicet Bio, Inc. (ACET) closed the last trading session at $8.3, gaining 5.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's  What You Should Know
Wall Street Analysts Predict a 25.57% Upside in Afya (AFYA): Here's What You Should Know

Shares of Afya (AFYA) have gained 0.2% over the past four weeks to close the last trading session at $14, but there could still be a solid upside left in the stock if short-term price targets of

Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect?
Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect?

Shares of BillionToOne (BLLN) have gained 1.4% over the past four weeks to close the last trading session at $85.92, but there could still be a solid upside left in the stock if short-term price

Methanex (MEOH) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Methanex (MEOH) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

A downtrend has been apparent in Methanex (MEOH) lately. While the stock has lost 5.1% over the past week, it could witness a trend reversal as a hammer chart pattern was formed in its last trading

Wall Street Analysts Predict a 35.71% Upside in Loar Holdings Inc. (LOAR): Here's  What You Should Know
Wall Street Analysts Predict a 35.71% Upside in Loar Holdings Inc. (LOAR): Here's What You Should Know

Shares of Loar Holdings Inc. (LOAR) have gained 8.8% over the past four weeks to close the last trading session at $62.34, but there could still be a solid upside left in the stock if short-term

Wall Street Analysts Think Copart (CPRT) Could Surge 36.79%: Read This Before Placing a Bet
Wall Street Analysts Think Copart (CPRT) Could Surge 36.79%: Read This Before Placing a Bet

Copart, Inc. (CPRT) closed the last trading session at $33.79, gaining 2.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Wall Street Analysts Think Concentra (CON) Could Surge 25.24%: Read This Before Placing a Bet
Wall Street Analysts Think Concentra (CON) Could Surge 25.24%: Read This Before Placing a Bet

Shares of Concentra Group (CON) have gained 11% over the past four weeks to close the last trading session at $25.32, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts See a 59.96% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High?
Wall Street Analysts See a 59.96% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High?

Contineum Therapeutics, Inc. (CTNM) closed the last trading session at $13.86, gaining 11.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price

Wall Street Analysts Believe Freshworks (FRSH) Could Rally 30.18%: Here's is How to Trade
Wall Street Analysts Believe Freshworks (FRSH) Could Rally 30.18%: Here's is How to Trade

Freshworks Inc. (FRSH) closed the last trading session at $9.08, gaining 7.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall

Should You Buy UBS (UBS) After Golden Cross?
Should You Buy UBS (UBS) After Golden Cross?

After reaching an important support level, UBS Group AG (UBS) could be a good stock pick from a technical perspective. UBS recently experienced a "golden cross" event, which saw its 50-day simple